| 帕唑帕尼的临床应用和药品不良反应的研究进展 |
| 投稿时间：2015-12-22 修订日期：2016-05-16 点此下载全文 |
| 引用本文：周陈建,赵嫏嬛,胡国新.帕唑帕尼的临床应用和药品不良反应的研究进展[J].药学实践杂志,2016,34(6):497~500 |
| 摘要点击次数: 1299 |
| 全文下载次数: 1664 |
|
|
| 中文摘要:帕唑帕尼是一种多靶点酪氨酸激酶抑制剂，研究发现帕唑帕尼主要用于治疗肾细胞癌、卵巢癌、乳腺癌和肺癌等疾病，并可能导致腹泻、高血压、头发褪色、恶心和厌食等不良反应。 |
| 中文关键词:帕唑帕尼 临床应用 不良反应 |
| |
| Progress of pazopanib in clinical applications and adverse drug reaction |
|
|
| Abstract:Pazopanib is a multi-targeted tyrosine kinase inhibitor, and is mainly used to treat renal cell carcinoma, ovarian cancer, breast cancer, and lung cancer. The researchers also found that pazopanib may cause diarrhea, hypertension, hair loss, nausea, and anorexia. This paper reviewed pazopanib clinical application and adverse reactions, and provided a basis for this medication. |
| keywords:pazopanib clinical application adverse reaction |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
|
|
|
